Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Affymetrix's Axiom Biobank Arrays; Agilent's Encore Multispan Liquid Handling System


Affymetrix this week introduced Axiom Biobank Arrays, a new menu of chips for affordably genotyping large sample collections such as those screened at biobanks, genome centers, and core labs.

The arrays, available in both catalog and custom versions, incorporate multiple content categories including a genome-wide association study panel of markers for high-coverage analysis in major ethnic groups, rare coding SNPs and indel markers for exome analysis from Affymetrix's Axiom Exome Array, ADME and other clinically relevant markers, and newly discovered loss-of-function variants, including sequence insertions and deletions from recent exome sequencing initiatives.

According to Affy, each of the Axiom Biobank Arrays contains more than 600,000 variants. Customers can request the inclusion of up to 50,000 additional variants and also have the ability to interchange variants in any of the content categories to meet the needs of their specific studies.

In addition, the company said it plans to expand its menu of Axiom Biobank Arrays by building a range of chips optimized for screening various sample collections, including those focused on particular diseases, specific geographic populations or ethnicities, and other study groups.

Affy is now accepting orders for the new Axiom Biobank Arrays and said it can ship custom versions of the array within four to six weeks. BioArray News discussed the new product launch with company representatives last month (BAN 10/16/2012).

Agilent Technologies recently launched its Encore Multispan Liquid Handling System.

According to Agilent, the system includes a dual, multispan pipetting system with two individual banks of multiple pipettes where each moves independently in multiple axes; a software package featuring a three-dimensional simulator that provides researchers with the ability to set up, visualize, and optimize their protocols remotely and offline prior to running valuable experiments on the system; and a built-in robotic arm that enables end-to-end workflow integrations.

The firm claims the system can be used to automate a number of applications, including microarray workflows. Agilent said the product will ship in the second quarter of 2013.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.